Ipsen welcomes TGA registration of treatment for primary biliary cholangitis

Christina Xinos, the medical director for Ipsen Australia, said, “We believe that this development demonstrates the rare focus we have on providing solutions for people living with cholestatic liver disease and improving patient outcomes.” …